CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Alogliptin Benzoate

苯甲酸阿格列汀 杂质对照品Alogliptin Benzoate Impurities

34 个杂质条目34 impurity entries

本页汇总 苯甲酸阿格列汀 的 34 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 34 impurity reference standards of Alogliptin Benzoate. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 苯甲酸阿格列汀(Alogliptin Benzoate)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDifferent chromatographic methods for determination of alogliptin benzoate, metformin hydrochloride, and metformin impurity in bulk and pharmaceutical dosage form
    Journal of separation science · 2021 · Magdy MA et al.  ·  PMID 33301650  ·  DOI
  2. 杂质研究Impurity studiesTrace Analysis of Genotoxic Impurity 3-Amino-N-Nitrosopiperidine in Alogliptin Benzoate by Ultra-Sensitive Liquid Chromatography Tandem Mass Spectrometry
    Biomedical chromatography : BMC · 2026 · Gharat MM et al.  ·  PMID 42538849  ·  DOI
  3. 杂质研究Impurity studiesDegradation Kinetics Study of Alogliptin Benzoate in Alkaline Medium by Validated Stability-Indicating HPTLC Method
    Journal of AOAC International · 2016 · Bodiwala KB et al.  ·  PMID 27608919  ·  DOI
  4. 分析方法Analytical MethodsSalting-out induced liquid-liquid microextraction for alogliptin benzoate determination in human plasma by HPLC/UV
    BMC chemistry · 2021 · Hammad SF et al.  ·  PMID 33451337  ·  DOI
  5. 分析方法Analytical MethodsNovel spectrofluorimetric quantification of alogliptin benzoate in biofluids exploiting its interaction with 4-chloro-7-nitrobenzofurazan
    Luminescence : the journal of biological and chemical luminescence · 2020 · Aref HA et al.  ·  PMID 31762136  ·  DOI

苯甲酸阿格列汀 —— 原料药与杂质对照品Alogliptin Benzoate — drug substance & impurities

共 35 个条目(含原料药本体)35 items incl. the drug substance
Alogliptin Benzoate structure
原料药 APIAPI
苯甲酸阿格列汀Alogliptin Benzoate
Alogliptin Benzoate
CAS No.850649-62-6
Chemical FormulaC25H27N5O4
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 12 structure
12
苯甲酸阿格列汀杂质12Alogliptin Benzoate Impurity 12
Alogliptin Benzoate Impurity 12
CAS No.2276323-24-9
Chemical FormulaC10H16N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 13 structure
13
苯甲酸阿格列汀杂质13Alogliptin Benzoate Impurity 13
Alogliptin Benzoate Impurity 13
CAS No.1353254-17-7
Chemical FormulaC13H17N3
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 14 structure
14
苯甲酸阿格列汀杂质14Alogliptin Benzoate Impurity 14
Alogliptin Benzoate Impurity 14
CAS No.2749357-07-9
Chemical FormulaC12H8ClN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 37 structure
37
苯甲酸阿格列汀杂质37Alogliptin Benzoate Impurity 37
Alogliptin Benzoate Impurity 37
CAS No.2565-47-1
Chemical FormulaC5H6N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 39 structure
39
苯甲酸阿格列汀杂质39Alogliptin Benzoate Impurity 39
Alogliptin Benzoate Impurity 39
CAS No.1134529-25-1
Chemical FormulaC8H9ClN2
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 43 structure
43
苯甲酸阿格列汀杂质43Alogliptin Benzoate Impurity 43
Alogliptin Benzoate Impurity 43
CAS No.130622-05-8
Chemical FormulaC12H21NO6
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 45 structure
45
苯甲酸阿格列汀杂质45Alogliptin Benzoate Impurity 45
Alogliptin Benzoate Impurity 45
CAS No.1473368-47-6
Chemical FormulaC12H25NO8S2
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 56 structure
56
苯甲酸阿格列汀杂质56Alogliptin Benzoate Impurity 56
Alogliptin Benzoate Impurity 56
CAS No.2900379-11-3
Chemical FormulaC4H3ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 57 structure
57
苯甲酸阿格列汀杂质57Alogliptin Benzoate Impurity 57
Alogliptin Benzoate Impurity 57
CAS No.2518277-40-0
Chemical FormulaC5H5ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 69 structure
69
苯甲酸阿格列汀杂质69Alogliptin Benzoate Impurity 69
Alogliptin Benzoate Impurity 69
CAS No.216854-24-9
Chemical FormulaC17H26N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 71 structure
71
苯甲酸阿格列汀杂质71Alogliptin Benzoate Impurity 71
Alogliptin Benzoate Impurity 71
CAS No.441790-71-2
Chemical FormulaC9H7NO
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 72 structure
72
苯甲酸阿格列汀杂质72Alogliptin Benzoate Impurity 72
Alogliptin Benzoate Impurity 72
CAS No.89942-45-0
Chemical FormulaC8H7NO
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 7-d3 structure
7-D3
苯甲酸阿格列汀杂质7-d3Alogliptin Benzoate Impurity 7-d3
Alogliptin Benzoate Impurity 7-d3
CAS No.1794937-18-0
Chemical FormulaC13H7D3ClN3O2
Purity>95%询价On request
Alogliptin Benzoate Impurity 73 structure
73
苯甲酸阿格列汀杂质73Alogliptin Benzoate Impurity 73
Alogliptin Benzoate Impurity 73
CAS No.7468-67-9
Chemical FormulaC8H5NO
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 74 structure
74
苯甲酸阿格列汀杂质74Alogliptin Benzoate Impurity 74
Alogliptin Benzoate Impurity 74
CAS No.3071566-33-8
Chemical FormulaC18H22N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 78 structure
78
苯甲酸阿格列汀杂质78Alogliptin Benzoate Impurity 78
Alogliptin Benzoate Impurity 78
CAS No.162955-48-8
Chemical FormulaC10H21NO4
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 79 structure
79
苯甲酸阿格列汀杂质79Alogliptin Benzoate Impurity 79
Alogliptin Benzoate Impurity 79
CAS No.882872-13-1
Chemical FormulaC5H6N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 80 structure
80
苯甲酸阿格列汀杂质80Alogliptin Benzoate Impurity 80
Alogliptin Benzoate Impurity 80
CAS No.59279-60-6
Chemical FormulaC12H21NO6
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 82 structure
82
苯甲酸阿格列汀杂质82Alogliptin Benzoate Impurity 82
Alogliptin Benzoate Impurity 82
CAS No.1949773-38-9
Chemical FormulaC18H21N5O2
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 83 structure
83
苯甲酸阿格列汀杂质83Alogliptin Benzoate Impurity 83
Alogliptin Benzoate Impurity 83
CAS No.1634664-96-2
Chemical FormulaC17H19N5O2
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 95 structure
95
苯甲酸阿格列汀杂质95Alogliptin Benzoate Impurity 95
Alogliptin Benzoate Impurity 95
CAS No.1338677-76-1
Chemical FormulaC10H16N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 96 structure
96
苯甲酸阿格列汀杂质96Alogliptin Benzoate Impurity 96
Alogliptin Benzoate Impurity 96
CAS No.3764-01-0
Chemical FormulaC4HCl3N2
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 97 (N1-Nitroso Alogliptin Benzoate Impurity 30) structure
97
苯甲酸阿格列汀杂质97 (N1-亚硝基苯甲酸阿格列汀杂质30)Alogliptin Benzoate Impurity 97 (N1-Nitroso Alogliptin Benzoate Impurity 30)
Alogliptin Benzoate Impurity 97 (N1-Nitroso Alogliptin Benzoate Impurity 30)
CAS No.3031851-92-7
Chemical FormulaC10H19N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 100(Atglistatin ) structure
100
苯甲酸阿格列汀杂质100(Atglistatin )Alogliptin Benzoate Impurity 100(Atglistatin )
Alogliptin Benzoate Impurity 100(Atglistatin )
CAS No.1469924-27-3
Chemical FormulaC17H21N3O
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 124 structure
124
苯甲酸阿格列汀杂质124Alogliptin Benzoate Impurity 124
Alogliptin Benzoate Impurity 124
CAS No.60271-06-9
Chemical FormulaC7H10N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 137 structure
137
苯甲酸阿格列汀杂质137Alogliptin Benzoate Impurity 137
Alogliptin Benzoate Impurity 137
CAS No.1354088-25-7
Chemical FormulaC13H17N3
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 141 (N-Nitroso Alogliptin Benzoate Impurity 52) structure
141
苯甲酸阿格列汀杂质141 (N-亚硝基苯甲酸阿格列汀杂质52)Alogliptin Benzoate Impurity 141 (N-Nitroso Alogliptin Benzoate Impurity 52)
Alogliptin Benzoate Impurity 141 (N-Nitroso Alogliptin Benzoate Impurity 52)
CAS No.1973427-27-8
Chemical FormulaC10H19N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 146 structure
146
苯甲酸阿格列汀杂质146Alogliptin Benzoate Impurity 146
Alogliptin Benzoate Impurity 146
CAS No.2272602-12-5
Chemical FormulaC13H17N3
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 150 structure
150
苯甲酸阿格列汀杂质150Alogliptin Benzoate Impurity 150
Alogliptin Benzoate Impurity 150
CAS No.2205147-14-2
Chemical FormulaC13H11ClN2O4
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 153 structure
153
苯甲酸阿格列汀杂质153Alogliptin Benzoate Impurity 153
Alogliptin Benzoate Impurity 153
CAS No.64148-19-2
Chemical FormulaC8H5Cl2N
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 154 structure
154
苯甲酸阿格列汀杂质154Alogliptin Benzoate Impurity 154
Alogliptin Benzoate Impurity 154
CAS No.2635-68-9
Chemical FormulaC8H4Cl3N
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 155 structure
155
苯甲酸阿格列汀杂质155Alogliptin Benzoate Impurity 155
Alogliptin Benzoate Impurity 155
CAS No.57991-54-5
Chemical FormulaC9H9NO
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 156 structure
156
苯甲酸阿格列汀杂质156Alogliptin Benzoate Impurity 156
Alogliptin Benzoate Impurity 156
CAS No.527-85-5
Chemical FormulaC8H9NO
Purity>95%询价On request
10mg25mg50mg100mg
Alogliptin Benzoate Impurity 157 structure
157
苯甲酸阿格列汀杂质157Alogliptin Benzoate Impurity 157
Alogliptin Benzoate Impurity 157
CAS No.13169-51-2
Chemical FormulaC8H8ClNO
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

苯甲酸阿格列汀 —— 研究文献与合成路线Alogliptin Benzoate — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 苯甲酸阿格列汀 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Alogliptin Benzoate. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Characterization of process-related impurities including forced degradation products of alogliptin benzoate and the development of the corresponding reversed-phase high-performance liquid chromatography method
    Zhou Y, Zhou W, Sun L, et al. · Journal of separation science · 2014 · 被引 11cited 11
  2. Degradation Kinetics Study of Alogliptin Benzoate in Alkaline Medium by Validated Stability-Indicating HPTLC Method
    Bodiwala KB, Shah S, Thakor J, et al. · Journal of AOAC International · 2016 · 被引 7cited 7
  3. Different chromatographic methods for determination of alogliptin benzoate, metformin hydrochloride, and metformin impurity in bulk and pharmaceutical dosage form
    Magdy MA, Ali NW, Taha AA, et al. · Journal of separation science · 2021 · 被引 6cited 6
  4. Trace Analysis of Genotoxic Impurity 3-Amino-N-Nitrosopiperidine in Alogliptin Benzoate by Ultra-Sensitive Liquid Chromatography Tandem Mass Spectrometry
    Gharat MM, Roy PT, Gosar AN, et al. · Biomedical chromatography : BMC · 2026

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

苯甲酸阿格列汀 杂质谱研究要点Alogliptin Benzoate — impurity profiling notes

下面这些是拿到 苯甲酸阿格列汀 的 35 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 35 impurity entries for Alogliptin Benzoate, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances